Elevated pro-inﬂammatory and lipotoxic mucosal lipidscharacterise irritable bowel syndrome-Reference-Cited by-同舟云学术

Elevated pro-inﬂammatory and lipotoxic mucosal lipidscharacterise irritable bowel syndrome

Published:2009 Issue:48 Volume:15 Page:6068
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Kajander Kajsa,Myllyluoma Eveliina,Kyrönpalo Sinikka,Rasmussen Martin,Sipponen Pentti,Mattila Ismo,Seppänen-Laakso Tuulikki,Vapaatalo Heikki,Orešič Matej,Korpela Riitta

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference45 articles.

1. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-2131.

2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491.

3. O'Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, O'Morain CA. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449-457.

4. Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, Martinez C, Casellas F, Saperas E, Malagelada JR. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007;56:203-209.

5. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome;International Journal of Molecular Sciences;2024-03-20

2. Dysregulated Glycerophospholipid Metabolism and ChAT Overexpression in Wrap-Restraint Stress-Induced IBS Mice: A Multi-Omics Approach to Gut-Brain Axis Disruption and Potential Therapeutic Targets;2023-09-18

3. Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review;Neurogastroenterology & Motility;2023-02-13

4. Metabolomic Profile of Different Dietary Patterns and Their Association with Frailty Index in Community-Dwelling Older Men and Women;Nutrients;2022-05-27

5. Lipidomics As Tools For Finding Biomarkers Of Intestinal Pathology: From Irritable Bowel Syndrome To Colorectal Cancer;Current Drug Targets;2021-07-07